T J Curiel
Overview
Explore the profile of T J Curiel including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
581
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hurez V, Padron A, Svatek R, Curiel T
Clin Exp Immunol
. 2016 Oct;
187(1):53-63.
PMID: 27690272
Immunotherapy is now experiencing unprecedented successes in treating various cancers based on new understandings of cancer immunopathogenesis. Nonetheless, although ageing is the biggest risk factor for cancer, the majority of...
2.
Lai R, McDonnell T, OConnor S, Medeiros L, Oudat R, Keating M, et al.
Leuk Res
. 2002 Jul;
26(9):849-55.
PMID: 12127561
Mantle cell lymphoma (MCL) is a distinct type of B-cell non-Hodgkin's lymphoma characterized by cyclin D1 overexpression and the cytogenetic abnormality, the t(11;14)(q13;q32). MCL cell lines have been difficult to...
3.
Zou W, Borvak J, Wei S, Isaeva T, Curiel D, Curiel T
Eur J Immunol
. 2001 Dec;
31(12):3833-9.
PMID: 11745405
Reciprocal regulation of opposing functions characterizes biological systems. We now show that adenovirus-infected plasmacytoid dendritic cells (PDC) inhibit monocyte to myeloid dendritic cell (MDC) differentiation and function, and that adenovirus-infected...
4.
Zou W, Machelon V, Borvak J, Nome F, Isaeva T, Wei S, et al.
Nat Med
. 2001 Dec;
7(12):1339-46.
PMID: 11726975
Dendritic-cell (DC) trafficking and function in tumors is poorly characterized, with studies confined to myeloid DCs (DC1s). Tumors inhibit DC1 migration and function, likely hindering specific immunity. The role of...
5.
Zou W, Borvak J, Marches F, Wei S, Galanaud P, Emilie D, et al.
J Immunol
. 2000 Oct;
165(8):4388-96.
PMID: 11035076
Monocyte-derived dendritic cells (MDDCs) activate naive T lymphocytes to induce adaptive immunity, effecting Th1 polarization through IL-12. However, little is known about other potential DC Th1 polarizing mechanisms, or how...
6.
Tillman B, de Gruijl T, Luykx-de Bakker S, Scheper R, Pinedo H, Curiel T, et al.
J Immunol
. 1999 Jun;
162(11):6378-83.
PMID: 10352250
Important therapeutic applications of genetically modified dendritic cells (DC) have been proposed; however, current vector systems have demonstrated only limited gene delivery efficacy to this cell type. By means of...
7.
Piche A, Kasono K, Johanning F, Curiel T, Curiel D
Gene Ther
. 1999 Feb;
5(9):1171-9.
PMID: 9930317
Epstein-Barr virus (EBV) causes lymphoproliferative diseases in immunocompromised patients and is associated with endemic Burkitt lymphoma, nasopharyngeal carcinoma and some cases of Hodgkin disease. The latent membrane protein 1 (LMP1)...
8.
Suzuki T, Piche A, Kasono K, Xiang J, Gomez-Navarro J, Moriuchi S, et al.
Biochem Biophys Res Commun
. 1998 Dec;
252(3):686-90.
PMID: 9837767
Subgroups of the B cell malignancies are known to be associated with Epstein-Barr virus (EBV) infection, especially in immunocompromised patients. These are fatal and refractory to conventional antineoplastic therapy. B...
9.
Berens R, Krug E, Nash P, Curiel T
J Infect Dis
. 1998 Apr;
177(4):1128-31.
PMID: 9534999
Toxoplasma gondii infection, like malaria, is sensitive to inhibition by artemisinin (ART). Mechanisms of action for ART in malaria treatment have been proposed, but little is known about its effects...
10.
Purner M, Berens R, Tomavo S, Lecordier L, Cesbron-Delauw M, Kotzin B, et al.
J Infect Dis
. 1998 Mar;
177(3):746-53.
PMID: 9498457
Toxoplasma gondii antigens are superantigens in mice. To investigate a superantigen effect in humans, lymphocytes from T. gondii-seronegative subjects were studied for proliferation to T. gondii antigens (TA). Marked cellular...